10.15

3.53% 0.3688

Neogenomics Inc (NEO)

Überblick Nachrichten Preisverlauf Optionskette Financials Warum fällt NEO? Forum Prognose Aktiensplit

Schlusskurs vom Vortag:

$9.78

Offen:

$9.6

24-Stunden-Volumen:

1.68M

Relative Volume:

0.50

Marktkapitalisierung:

$1.31B

Einnahmen:

$628.25M

Nettoeinkommen (Verlust:

$-78.55M

KGV:

-16.37

EPS:

-0.62

Netto-Cashflow:

$-29.73M

1W Leistung:

+2.07%

1M Leistung:

+11.26%

6M Leistung:

+31.49%

1J Leistung:

-28.39%

1-Tages-Spanne:

$9.60

$10.28

1-Wochen-Bereich:

$9.42

$10.58

52-Wochen-Spanne:

$4.72

$19.11

Neogenomics Inc Stock (NEO) Company Profile

Firmenname

Neogenomics Inc

Sektor

Healthcare (1140)

Branche

Diagnostics & Research (53)

Telefon

(239) 768-0600

Adresse

9490 NEOGENOMICS WAY, FORT MYERS, FL

Mitarbeiter

2,200

Twitter

@NeoGenomics

Nächster Verdiensttermin

2025-02-18

Neueste SEC-Einreichungen

NEO's Discussions on Twitter

Vergleichen Sie NEO mit anderen Aktien

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
NEO Neogenomics Inc	10.12	1.27B	628.25M	-78.55M	-29.73M	-0.62
TMO Thermo Fisher Scientific Inc	564.52	212.23B	43.74B	6.58B	6.11B	17.31
DHR Danaher Corp	213.41	151.20B	24.27B	3.50B	5.02B	4.8589
IDXX Idexx Laboratories Inc	719.26	57.84B	4.04B	985.66M	774.34M	12.01
A Agilent Technologies Inc	146.79	41.02B	6.79B	1.22B	1.09B	4.2644
IQV Iqvia Holdings Inc	212.01	36.42B	15.90B	1.28B	2.21B	7.2842

Neogenomics Inc Stock (NEO) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2025-07-30	Herabstufung	BTIG Research	Buy → Neutral
2025-07-29	Herabstufung	William Blair	Outperform → Mkt Perform
2025-05-15	Eingeleitet	Guggenheim	Neutral
2025-04-30	Herabstufung	Leerink Partners	Outperform → Market Perform
2025-01-13	Herabstufung	The Benchmark Company	Buy → Hold
2024-12-10	Eingeleitet	Jefferies	Buy
2024-05-01	Fortgesetzt	Craig Hallum	Buy
2023-12-29	Bestätigt	BTIG Research	Buy
2023-08-21	Hochstufung	Stephens	Equal-Weight → Overweight
2023-05-16	Herabstufung	Raymond James	Outperform → Mkt Perform
2023-05-09	Hochstufung	BTIG Research	Neutral → Buy
2023-02-24	Hochstufung	The Benchmark Company	Hold → Buy
2023-02-01	Hochstufung	Needham	Hold → Buy
2022-08-26	Herabstufung	The Benchmark Company	Buy → Hold
2022-08-22	Herabstufung	Needham	Buy → Hold
2022-06-03	Eingeleitet	Piper Sandler	Overweight
2022-03-29	Herabstufung	BofA Securities	Buy → Neutral
2022-03-29	Herabstufung	Stephens	Overweight → Equal-Weight
2022-01-18	Fortgesetzt	Stephens	Overweight
2021-12-16	Eingeleitet	Cowen	Outperform
2021-11-05	Herabstufung	Morgan Stanley	Overweight → Equal-Weight
2021-10-14	Hochstufung	Raymond James	Mkt Perform → Outperform
2021-06-03	Eingeleitet	Goldman	Buy
2021-02-25	Fortgesetzt	Needham	Buy
2021-02-25	Herabstufung	Raymond James	Outperform → Mkt Perform
2021-01-28	Eingeleitet	Truist	Buy
2020-12-11	Fortgesetzt	BTIG Research	Buy
2020-10-28	Bestätigt	Needham	Buy
2020-09-09	Eingeleitet	Morgan Stanley	Overweight
2020-08-28	Eingeleitet	Guggenheim	Buy
2020-07-29	Bestätigt	Needham	Buy
2020-06-25	Eingeleitet	BofA/Merrill	Buy
2020-04-21	Fortgesetzt	Stephens	Overweight
2020-03-02	Fortgesetzt	Craig Hallum	Buy
2020-02-28	Hochstufung	First Analysis Sec	Outperform → Strong Buy
2020-01-23	Herabstufung	First Analysis Sec	Strong Buy → Outperform
2019-10-30	Bestätigt	Needham	Buy
2019-05-01	Bestätigt	Needham	Buy
2019-03-29	Bestätigt	Needham	Buy
2019-01-03	Eingeleitet	Needham	Buy
2018-10-24	Hochstufung	First Analysis Sec	Outperform → Strong Buy
2018-08-21	Eingeleitet	Leerink Partners	Outperform
2018-05-02	Herabstufung	First Analysis Sec	Overweight → Equal-Weight
2017-09-11	Herabstufung	BTIG Research	Buy → Neutral
2017-08-24	Eingeleitet	Gabelli & Co	Buy
2016-12-15	Eingeleitet	Cantor Fitzgerald	Overweight

Alle ansehen

Neogenomics Inc Aktie (NEO) Neueste Nachrichten

06:11 AM

Using RSI to spot recovery in NeoGenomics Inc.Bull Run & Daily Risk Controlled Trade Plans - newser.com

06:11 AM

05:33 AM

Will earnings trigger a reversal in NeoGenomics Inc.2025 Market Sentiment & Fast Moving Market Watchlists - newser.com

05:33 AM

05:21 AM

Will a bounce in NeoGenomics Inc. offer an exitJuly 2025 Reactions & High Accuracy Investment Signals - newser.com

05:21 AM

05:05 AM

Chart overlay techniques for tracking NeoGenomics Inc.2025 Price Action Summary & Expert Curated Trade Ideas - newser.com

05:05 AM

05:03 AM

Sector ETF performance correlation with NeoGenomics Inc.Weekly Volume Report & Fast Gain Swing Alerts - newser.com

05:03 AM

04:58 AM

Developing predictive dashboards with NeoGenomics Inc. dataJuly 2025 Sentiment & Safe Entry Point Alerts - newser.com

04:58 AM

04:44 AM

Will NeoGenomics Inc. (NG9) stock announce a stock splitMarket Performance Report & Long-Term Capital Growth Ideas - newser.com

04:44 AM

03:38 AM

Price momentum metrics for NeoGenomics Inc. explained2025 Volatility Report & Expert Curated Trade Setups - newser.com

03:38 AM

03:29 AM

Is NeoGenomics Inc. trending in predictive chart models2025 Investor Takeaways & Community Consensus Trade Signals - newser.com

03:29 AM

NeoGenomics Q3 2025 Earnings: Revenue Beat Offset by EPS Miss and Margin PressureNews and Statistics - IndexBox

03:29 AM

02:16 AM

How analysts rate NeoGenomics Inc. stock today2025 Price Action Summary & AI Based Trade Execution Alerts - newser.com

02:16 AM

12:38 PM

The Top 5 Analyst Questions From NeoGenomics’s Q3 Earnings Call - Yahoo Finance

12:38 PM

Nov 03, 2025

Technical analysis overview for NeoGenomics Inc. stockJuly 2025 Intraday Action & Capital Efficient Trading Techniques - newser.com

Nov 03, 2025

Is NeoGenomics Inc. (NG9) stock supported by free cash flow2025 Price Momentum & Weekly High Potential Alerts - newser.com

Nov 03, 2025

NeoGenomics (NEO): Buy, Sell, or Hold Post Q3 Earnings? - Yahoo Finance

Nov 03, 2025

Is NeoGenomics Inc. stock affected by interest rate hikesEarnings Risk Report & Risk Managed Investment Entry Signals - newser.com

Nov 03, 2025